A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor

NCT04042116 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

227

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision

Conditions

Advanced Solid Tumor
Gynecologic Cancer

Interventions

DRUG: Lucitanib
DRUG: Lucitanib
DRUG: Lucitanib
DRUG: Nivolumab

Sponsor

Clovis Oncology, Inc.

Collaborators

[object Object]
[object Object]